Clinical Trials Browser

OTHER × Breast Neoplasms, Male × eribulin × Clear all

NCT01372579 2019-06-07

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms